Home › Non-Hodgkin Lymphoma › Illinois › Chicago

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Chicago, IL

Isang pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Nagre-recruitPhase 2

Cancer Treatment Centers of America-Chicago, Chicago

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

The University of Chicago Medical Center (UCMC), Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

Lurie Children's Hospital-Chicago, Chicago

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nagre-recruitPhase 1/2

University of Chicago Medical Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Nagre-recruitPhase 1

The David and Etta Jonas Center for Cellular Therapy, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06528301

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Nagre-recruitObservasyonal na pag-aaral

Robert H Lurie Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Northwestern, Chicago
University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Robert H Lurie Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

University of Illinois at Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Northwestern Memorial Hospital, Chicago
Rush University Medical Center, Chicago
University of Illinois at Chicago, Chicago
at 2 pa

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Nagre-recruitPhase 1

University of Chicago, Chicago

Edad 13 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2

Northwestern Memorial Hospital, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

John H Stroger Jr Hospital of Cook County, Chicago
Advocate Illinois Masonic Medical Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Nagre-recruitPhase 4

Northwestern University, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Nagre-recruitPhase 4

Northwestern University, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Northwestern Memorial Hospital, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chicago

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.